tiprankstipranks
Sinopharm Group Co (SHTDY)
OTHER OTC:SHTDY

Sinopharm Group Co (SHTDY) Stock Price & Analysis

21 Followers

SHTDY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$11.37 - $17.48
Previous Close$12.63
Volume2.00
Average Volume (3M)12.30K
Market Cap
$7.88B
Enterprise Value$21.59B
Total Cash (Recent Filing)¥32.15B
Total Debt (Recent Filing)¥91.90B
Price to Earnings (P/E)6.2
Beta0.08
Apr 26, 2024
EPS EstimateN/A
Dividend Yield3.69%
Share Statistics
EPS (TTM)2.04
Shares OutstandingN/A
10 Day Avg. Volume12,119
30 Day Avg. Volume12,298
Standard Deviation0.10
R-Squared0.08
Alpha-0.00730
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%<0.01%0.02%99.97%
0.00%
Insiders
0.02% Other Institutional Investors
99.97% Public Companies and
Individual Investors

SHTDY FAQ

What was Sinopharm Group Co’s price range in the past 12 months?
Sinopharm Group Co lowest stock price was $11.37 and its highest was $17.48 in the past 12 months.
    What is Sinopharm Group Co’s market cap?
    Currently, no data Available
    When is Sinopharm Group Co’s upcoming earnings report date?
    Sinopharm Group Co’s upcoming earnings report date is Apr 26, 2024 which is 7 days ago.
      How were Sinopharm Group Co’s earnings last quarter?
      Sinopharm Group Co released its earnings results on Mar 25, 2024. The company reported $1.096 earnings per share for the quarter, beating the consensus estimate of N/A by $1.096.
        Is Sinopharm Group Co overvalued?
        According to Wall Street analysts Sinopharm Group Co’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Sinopharm Group Co pay dividends?
          Sinopharm Group Co pays a Annually dividend of $0.49 which represents an annual dividend yield of 3.69%. See more information on Sinopharm Group Co dividends here
            What is Sinopharm Group Co’s EPS estimate?
            Sinopharm Group Co’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Sinopharm Group Co have?
            Sinopharm Group Co has 268,362,150 shares outstanding.
              What happened to Sinopharm Group Co’s price movement after its last earnings report?
              Sinopharm Group Co reported an EPS of $1.096 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.212%.
                Which hedge fund is a major shareholder of Sinopharm Group Co?
                Currently, no hedge funds are holding shares in SHTDY
                ---

                Sinopharm Group Co Stock Smart Score

                2
                Underperform
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10

                Technicals

                SMA
                Negative
                20 days / 200 days
                Momentum
                -20.04%
                12-Months-Change

                Fundamentals

                Return on Equity
                12.57%
                Trailing 12-Months
                Asset Growth
                3.02%
                Trailing 12-Months

                Company Description

                Sinopharm Group Co

                Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment is distributes medical devices, financial leasing ,production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Pfizer
                Novartis
                Johnson & Johnson
                Popular Stocks
                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis